ÂÜÀòÂÒÂ×

Mark Murcko is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Member of the Board of Directors and Founding Chief Scientific Officer at Dewpoint Therapeutics since November 2018. Mark is also a Founder and Board Member at Relay Therapeutics since February 2016, and holds board positions at BioHybrid Solutions, HIBio, RADD Pharmaceuticals, and the Museum of Science. Additionally, Mark functions as a Strategic Advisor and Board member at Octant and has been a dedicated member of the Board of Trustees for Gordon Research Conferences since October 2016. As a Senior Lecturer in the Department of Biological Engineering at MIT since 2012, Mark shares extensive knowledge gained from an educational background that includes a PhD in Chemistry from Yale University and a BS in Chemistry and Applied Math from Fairfield University. Mark is also the Principal at Disruptive Biomedical, LLC, since November 2011.